Skip to content
Mid-Atlantic Business Group On Health
Smiling business people.


The MidAtlantic Business Group on Health is an association of employer health care purchasers that drives cost-effective healthcare, through value-based purchasing.

Our site is intended to showcase the following:

Please browse our site to learn about who we are. Then click here to join us in our mission!

August 20, 8:30 AM - 12:00 PM       BWI Marriott
EFFECTIVELY Communicating Health Benefits

Are you spending too much time explaining their health benefits to your employees?  You are not alone, most benefits professionals do.  Join us on August 20 to hear from experts who have done the research for you

  • How much -- or how little do consumers understand about health benefits?
  • What you need to tell them so they choose the right plan in the first place?
  • A large employer shares an example web site that you can use to educate your own employees, retirees, and dependents.

Click HERE for more information and to register.

SAVE THE DATE!  October 13, 2015,  8:30 AM -  3:30 PM    BWI Marriott
Managing Specialty Drugs:  A Multi-Stakeholder Forum 

The new Hepatitis C drugs have made the challenges created by biologics/specialty drugs.  New entrants for cholesterol and other common conditions are on the way, and will make managing Specialty Drugs even more important.  Join us to hear how all the parties affecting this challenge are helping manage the challenge: or not. 

Expert Presenters:  

  • Brenda Motheral, PhD, is CEO of Artemetrx.  She began her career as a research scientist in the area of cost-effectiveness of pharmaceuticals. Since that time her work has focused on leveraging applied research for drug coverage decisions, identifying and designing new products, and implementing large health services programs.
  • Len Nichols, PhD, is a highly respected healthcare economist, Director of the Center for Health Policy Research and Ethics, and Professor of Health Policy, George Mason University.  Len has testified before both the House Committee on Ways and Means as well as the Senate Budget Committee, and was quoted on drug pricing in the New York Times as recently as July 23, 2015.


  • Panels of stakeholders from employers, prescribers, PBMs, and drug manufacturers  
© 2015 Mid-Atlantic Business Group On Health